In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Going Grassroots In Health Debate: New AdvaMed Head Aims To Grow Base

This article was originally published in The Gray Sheet

Executive Summary

The device lobby is trying to build a broader coalition in patient and physician communities to maximize its leverage during what could turn out to be the industry's most challenging period on the policy front in years

You may also be interested in...



McClellan Sees Tight Budget, Not New President, Driving Health Policy In ’09

Budgetary obstacles will likely hold health care reforms to relatively modest changes in 2009, regardless of the outcome of the November presidential elections, according to former Centers for Medicare & Medicaid Services Administrator Mark McClellan

McClellan Sees Tight Budget, Not New President, Driving Health Policy In ’09

Budgetary obstacles will likely hold health care reforms to relatively modest changes in 2009, regardless of the outcome of the November presidential elections, according to former Centers for Medicare & Medicaid Services Administrator Mark McClellan

Patients Deserve More Information On Potentially Faulty Devices – Maisel

A leading expert on medical device safety wants Congress to compel FDA and manufacturers to provide more consumer protections for patients with implanted devices

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025911

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel